Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
medical device
7
×
national blog main
7
×
new york blog main
raleigh-durham blog main
san diego blog main
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
7
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
national top stories
new york top stories
raleigh-durham top stories
san diego top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
clinical trials
fda
amgen
deals
eli lilly
startups
bristol-myers squibb
cancer drugs
cancer immunotherapy
merck
abbvie
What
roundup
bio
companies
drug
disease
drugs
fda
make
nash
new
news
sciences
treatment
week
according
acquisitions
adding
aims
akcea
appetite
approval
approved
arguments
big
biggest
biotech
biotechs
black
bread
build
butter
buy
buyout
cancer
cases
cash
centers
ceo
cigarettes
class
Language
unset
Current search:
" national blog main "
×
" medical device "
×
" seattle top stories "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M